==== Reference: Usmani SS, Bedi G, Samuel JS, Singh S, Kalra S, Kumar P, et al. (2017) THPdb: Database of FDA-approved peptide and protein therapeutics. PLoS ONE 12(7) e0181748.====

Browse result page of THPdb

The total number entries retrieved from this search are 2
ID1431ThPPIDTh1073NameAlemtuzumabPeptide SequenceHeavy Chain 1: QVQLQ Full viewLength2839Functional ClassificationIIaDiseaseCancerBrandCAMPATHCompanyGenzyme CorporationPhysical AppearanceSterile, clear, colorless, isotonic solution (pH 6.8-7.4)Route of AdministartionIntravenous infusionCategoryN.A. TargetN.A.
ID1432ThPPIDTh1073NameAlemtuzumabPeptide SequenceHeavy Chain 1: QVQLQ Full viewLength2389Functional ClassificationIIaDiseaseCancerBrandLEMTRADACompanyGenzyme CorporationPhysical AppearanceLEMTRADA is a sterile, clear and colorless to slightly yellow, solution (pH 7.2±0.2) for infusion.Route of AdministartionIntravenous infusionCategoryNA TargetNA